- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Vmax.
Displaying page 1 of 1.
EudraCT Number: 2009-014263-40 | Sponsor Protocol Number: MEL01 | Start Date*: 2009-12-14 |
Sponsor Name:Penwest Pharmaceuticals Co. | ||
Full Title: A Phase 2a, Double Blind, Randomized, Placebo-controlled, 28 day, Two-arm, Parallel Group Study of A0001 in Patients with the A3243G Mitochondrial DNA Point Mutation and Evidence of Impaired Mitoch... | ||
Medical condition: A3243G mitochondrial DNA point mutation and evidence of impaired mitochondrial function | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001497-27 | Sponsor Protocol Number: BY1023/M3-713 | Start Date*: 2005-08-12 |
Sponsor Name:ALTANA Pharma AG | ||
Full Title: Effect of pantoprazole on sleep-related breathing disorders | ||
Medical condition: Sleep-related breathing disorders | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-005063-13 | Sponsor Protocol Number: Repha_1410 | Start Date*: 2017-05-08 | |||||||||||
Sponsor Name:Repha GmbH | |||||||||||||
Full Title: Investigation of Efficacy, Safety, Acid Resistance and Mode of Action of Lipases in Nortase and Kreon with the Pancreo-Lip 13C breath test in Subjects with Severe Exocrine Pancreatic Insufficiency | |||||||||||||
Medical condition: Severe exocrine pancreatic insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000805-27 | Sponsor Protocol Number: MEIN/10/Ran-Did/001 | Start Date*: 2012-10-23 | |||||||||||
Sponsor Name:Menarini International Operations Luxembourg S.A., Avenue de la Gare, 1611 Luxembourg, Luxembourg | |||||||||||||
Full Title: Effect of Ranolazine in Heart Failure Patients with Preserved Ejection Fraction | |||||||||||||
Medical condition: Heart failure patients with preserved ejection fraction (HFpEF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000447-27 | Sponsor Protocol Number: USKH_VL1 | Start Date*: 2012-07-25 |
Sponsor Name:Universitätsklinikum Schleswig-Holstein, Campus Kiel | ||
Full Title: Open Label Study for the Functional Characterization of Drug Metabolism and Transport in patients before routine visceral surgery | ||
Medical condition: Pharmacokinetic trial in patients, with a good general condition before standard abdominal surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Temporarily Halted) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
